Michael Klichinsky
Founder at CARISMA THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Michael Klichinsky is the founder.
He founded CTx Operations, Inc. in 2016 and holds the title of Chief Scientific Officer.
He also founded Carisma Therapeutics, Inc. in 2016 and holds the title of Chief Scientific Officer.
Dr. Klichinsky has a doctorate degree from the University of Pennsylvania and a doctorate degree from the University of the Sciences in Philadelphia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-30 | 484,347 ( 1.20% ) | 1 M $ | 2024-03-30 |
Michael Klichinsky active positions
| Companies | Position | Start |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Founder | 2015-12-31 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Founder | 2015-12-31 |
Training of Michael Klichinsky
| University of Pennsylvania | Doctorate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Michael Klichinsky
